We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App





SARS-CoV-2 Neutralizing Antibodies Fade Quickly in Recovering COVID-19 Patients After Symptoms Subside

By HospiMedica International staff writers
Posted on 19 Oct 2020
Print article
Illustration
Illustration
SARS-CoV-2 antibody levels in the blood of COVID-19 patients decline rapidly during the weeks after their bodies have cleared the virus and symptoms have subsided, according to a new study.

Researchers at the University of Montreal (Montreal, QC, Canada) are attempting to understand how the levels of antibodies change over time in order to optimize the use of blood plasma from recovering patients for treating those with severe COVID symptoms. Their research is also critical for understanding the efficacy of COVID-19 vaccines and finding out whether previously infected people face a risk of re-infection. Previous studies have revealed that antibodies against the SARS-CoV-2 spike protein peak two or three weeks following the onset of symptoms. In an earlier study of more than 100 patients by researchers at the University of Montreal, it was found that plasma’s ability to neutralize the SARS-CoV-2 virus declined significantly between three and six weeks after the onset of symptoms.

In the new longitudinal study, the team analyzed blood samples collected at one-month intervals from 31 individuals who were recovering from COVID-19. The researchers measured the levels of immunoglobulins that act against the coronavirus S protein and tested the ability of the antibodies to neutralize SARS-CoV-2. They found that the levels of Immunoglobulins G, A, and M that target the binding site declined between six and 10 weeks after the onset of symptoms and the ability of the antibodies to neutralize the virus also reduced over the same period.

Small studies have found that convalescent plasma can reduce the severity of illness and reduce hospitalization in COVID-19 patients, but it is yet to demonstrate benefits in randomized trials. Recovering patients cannot donate blood until at least 14 days after symptoms have subsided in order to allow their body to clear the viral particles, although the researchers have concluded that convalescent plasma must be collected during a specific window of time after recovery for deriving any clear benefits.

“We don’t want to transfuse the virus, just transfuse the antibodies,” said Andrés Finzi, Ph.D., at the University of Montreal. “But at the same time, our work shows that the capacity of the plasma to neutralize viral particles is going down during those first weeks.”

Related Links:
University of Montreal

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Needlefree Closed System Transfer Device
ChemoClave

Print article

Channels

Critical Care

view channel
Image: Researchers have developed an advanced shear-thinning hydrogel for aneurysm repair (Photo courtesy of TIBI)

New Hydrogel Features Enhanced Capabilities for Treating Aneurysms and Halting Progression

Aneurysms can develop in blood vessels in different body areas, often as a result of atherosclerosis, infections, inflammatory diseases, and other risk factors. These conditions lead to chronic inflammation,... Read more

Surgical Techniques

view channel
Image: The living replacement knee will be tested in clinical trials within five years (Photo courtesy of ARPA-H)

Living Knee Replacement to Revolutionize Osteoarthritis Treatment

Osteoarthritis is the most prevalent type of arthritis, characterized by the progressive deterioration of cartilage, or the protective tissue covering the bone ends, resulting in pain, stiffness, and impaired... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.